Granules India has reported results for fourth quarter and year ended March 31, 2021.
The company has reported a fall of 29.49% in its net profit at Rs 142.25 crore for the quarter under review as compared to Rs 201.75 crore for the same quarter in the previous year. However, total income of the company increased by 55.77% at Rs 784.61 crore for Q4FY21 as compared Rs 503.70 crore for the corresponding quarter previous year.
On the consolidated basis, the company has reported a rise of 38.15% in its net profit at Rs 127.57 crore for the quarter under review as compared to Rs 92.34 crore for the same quarter in the previous year. Total income of the company increased by 28.95% at Rs 802.59 crore for Q4FY21 as compared Rs 622.40 crore for the corresponding quarter previous year.
For the year ended March 31, 2021, the company has reported a rise of 24.48% in its net profit at Rs 552.78 crore as compared to Rs 444.07 crore for the previous year. Total income of the company increased by 34.77% at Rs 3148.71 crore for year under review as compared to Rs 2336.39 crore for year ended March 31, 2020.
For the year ended March 31, 2021, on the consolidated basis, the company has reported a rise of 63.82% in its net profit at Rs 549.46 crore as compared to Rs 335.40 crore for the previous year. Total income of the company increased by 23.88% at Rs 3264.42 crore for year under review as compared to Rs 2635.20 crore for year ended March 31, 2020.
| Company Name | CMP |
|---|---|
| Sun Pharma Inds. | 1675.20 |
| Dr. Reddys Lab | 1235.40 |
| Cipla | 1238.30 |
| Zydus Lifesciences | 942.55 |
| Lupin | 2324.25 |
| View more.. | |
MoneyWorks4Me is a SEBI-registered Investment Adviser (IA) dedicated to helping investors build long-term wealth through transparent, research-driven, conflict-free guidance. Founded in 2008, we started our journey as a Research Analyst (RA), providing deep fundamental analysis, intrinsic value insights, and long-term investing frameworks for Indian equities. In 2017, we transitioned to a full-fledged SEBI-registered Investment Adviser, strengthening our commitment to acting as a fiduciary—always putting the investor’s interest first.
To become India’s most trusted, research-powered fiduciary advisory platform—where every investor, regardless of experience, can make calm, confident, and well-reasoned investment decisions.
MoneyWorks4Me ensures this through: